IART
Integra Lifesciences Holdings Corp
Price:  
27.54 
USD
Volume:  
835,428.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IART EV/EBITDA

62.1%
Upside

As of 2024-05-20, the EV/EBITDA ratio of Integra Lifesciences Holdings Corp (IART) is 9.61. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IART's latest enterprise value is 3,428.73 mil USD. IART's TTM EBITDA according to its financial statements is 356.77 mil USD. Dividing these 2 quantities gives us the above IART EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 13.9x - 17.6x 16.4x
Forward P/E multiples 16.4x - 24.9x 17.6x
Fair Price 28.18 - 63.81 44.65
Upside 2.3% - 131.7% 62.1%
27.54 USD
Stock Price
44.65 USD
Fair Price

IART EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-17 9.61
2024-05-16 9.60
2024-05-15 9.37
2024-05-14 9.37
2024-05-13 9.32
2024-05-10 9.27
2024-05-09 9.12
2024-05-08 9.03
2024-05-07 9.07
2024-05-06 8.64
2024-05-03 9.91
2024-05-02 9.88
2024-05-01 9.97
2024-04-30 9.97
2024-04-29 9.98
2024-04-26 9.79
2024-04-25 9.80
2024-04-24 10.02
2024-04-23 10.02
2024-04-22 9.93
2024-04-19 9.86
2024-04-18 10.51
2024-04-17 10.58
2024-04-16 10.55
2024-04-15 10.61
2024-04-12 10.77
2024-04-11 10.85
2024-04-10 11.05
2024-04-09 11.17
2024-04-08 11.13
2024-04-05 11.03
2024-04-04 10.99
2024-04-03 11.01
2024-04-02 10.93
2024-04-01 11.19
2024-03-28 11.35
2024-03-27 11.22
2024-03-26 10.98
2024-03-25 10.90
2024-03-22 10.98
2024-03-21 11.13
2024-03-20 11.06
2024-03-19 11.10
2024-03-18 11.09
2024-03-15 11.19
2024-03-14 11.22
2024-03-13 11.43
2024-03-12 11.45
2024-03-11 11.52
2024-03-08 11.64